{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:14:35Z","timestamp":1793726075973,"version":"4.6.1"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:00:00Z","timestamp":1620950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>This study aimed to explore the risk factors attributed to osteoporosis in newly type 2 diabetes mellitus (T2DM) patients. This study aimed to recruit 244 T2DM patients and 218 non-diabetic controls. We collected demographic characteristics, medical history, bone mineral density and biomarkers including bone specific alkaline phosphatase (BALP), osteocalcin, N-terminal peptide of type I procollagen (P1NP), tartrate-resistant acid phosphatase 5b (TRCAP-5b), \u03b2-Cross Laps of type I collagen-containing cross-linked C-telopeptide (\u03b2-CTX), 25-hydroxyvitamin D, parathyroid hormone were recorded or detected. Bone mineral density (BMD) was our primary outcome. Based on the result of BMD, we divided both the control group and T2DM group into three subgroups: normal bone mass, osteopenia and osteoporosis. In control group, we found age, sex, menopausal status, BMI, P1NP, BALP, TRACP-5b, osteocalcin, and corrected serum calcium are differential among three subgroups. In T2DM group, we found age, sex, menopausal status, drinking status, BMI, HbA1c, TRACP-5b and OC were differential among three subgroups. In T2DM and control groups, age, female, postmenopausal status, BALP, TRACP-5b and osteocalcin were positively correlated while BMI was negatively correlated with osteoporosis. In control group, \u03b2-CTX was positively correlated with osteoporosis. In T2DM group, HbA1c and corrected serum calcium concentration were positively correlated with osteoporosis. After further adjustment of age, BMI in male, TRACP-5b was positively correlated with the risk of osteoporosis in newly diagnosed T2DM. After adjusted of age, BMI and menopausal status in female, OC was positively correlated with the risk of osteoporosis in newly diagnosed T2DM and controls. In female T2DM, BALP and P1NP were positively correlated with the risk of osteoporosis. In conclusion, age, BMI and menopausal status are common risk factors for osteoporosis in diabetic and non-diabetic patients, however TRACP-5b, BALP and osteocalcin are special risk factors for osteoporosis in newly diagnosed T2DM patients but not non-diabetic patients, which may be applied to identify osteoporosis risk in T2DM patients, but this result needs to be proven with fracture data.<\/jats:p>","DOI":"10.3389\/fendo.2021.531904","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:31:22Z","timestamp":1620977482000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":43,"title":["Correlation of Osteoporosis in Patients With Newly Diagnosed Type 2 Diabetes: A Retrospective Study in Chinese Population"],"prefix":"10.3389","volume":"12","author":[{"given":"Yuhua","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lige","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"Idf Diabetes Atlas: Global Estimates of Diabetes Prevalence for 2017 and Projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"B2","doi-asserted-by":"publisher","first-page":"6989453","DOI":"10.1155\/2016\/6989453","article-title":"Complications of Diabetes 2016","volume":"2016","author":"Papatheodorou","year":"2016","journal-title":"J Diabetes Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/aje\/kwm106","article-title":"Systematic Review of Type 1 and Type 2 Diabetes Mellitus and Risk of Fracture","volume":"166","author":"Janghorbani","year":"2007","journal-title":"Am J Epidemiol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2015.05.007","article-title":"Fracture Risk in Patients With Newly Diagnosed Type 2 Diabetes: A Retrospective Database Analysis in Primary Care","volume":"29","author":"Rathmann","year":"2015","journal-title":"J Diabetes its Complications"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.715","article-title":"Association of BMD and FRAX Score With Risk of Fracture in Older Adults With Type 2 Diabetes","volume":"305","author":"Schwartz","year":"2011","journal-title":"Jama"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3538","article-title":"Comparison of Methods for Improving Fracture Risk Assessment in Diabetes: The Manitoba Bmd Registry","volume":"33","author":"Leslie","year":"2018","journal-title":"J Bone Min Res Off J Am Soc Bone Min Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2016.153","article-title":"Mechanisms of Diabetes Mellitus-Induced Bone Fragility","volume":"13","author":"Napoli","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2012.01583.x","article-title":"Association Between Hypoglycaemic Events and Fall-Related Fractures in Medicare-covered Patients With Type 2 Diabetes","volume":"14","author":"Johnston","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"B9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.14283\/jfa.2016.110","article-title":"Sarcopenia Trials in Specific Diseases: Report by the International Conference on Frailty and Sarcopenia Research Task Force","volume":"5","author":"Vellas","year":"2016","journal-title":"J frailty Aging"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-016-3527-5","article-title":"Association of Bone Mineral Density and Diabetic Retinopathy in Diabetic Subjects: The 2008-2011 Korea National Health and Nutrition Examination Survey","volume":"27","author":"Lim","year":"2016","journal-title":"Osteoporosis Int"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-1152","article-title":"Diabetes-Related Complications, Glycemic Control, and Falls in Older Adults","volume":"31","author":"Schwartz","year":"2008","journal-title":"Diabetes Care"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-018-4650-2","article-title":"Diagnosis and Management of Bone Fragility in Diabetes: An Emerging Challenge","volume":"29","author":"Ferrari","year":"2018","journal-title":"Osteoporosis Int"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0222571","DOI":"10.1371\/journal.pone.0222571","article-title":"Prevalent Vertebral Fracture is Dominantly Associated With Spinal Microstructural Deterioration Rather Than Bone Mineral Density in Patients With Type 2 Diabetes Mellitus","volume":"14","author":"Yamamoto","year":"2019","journal-title":"PloS One"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2017.05.008","article-title":"Effect of Anti-Diabetic Drugs on Bone Metabolism: Evidence From Preclinical and Clinical Studies","volume":"69","author":"Adil","year":"2017","journal-title":"Pharmacol Rep PR"},{"key":"B15","volume-title":"Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications:Report of a WHO Consultation","author":"Tan MC","year":"1999"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650090802","article-title":"The Diagnosis of Osteoporosis","volume":"9","author":"Kanis","year":"1994","journal-title":"J Bone Min Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3757","article-title":"The Prevalence of Osteoporosis in China, a Nationwide, Multicenter DXA Survey","volume":"34","author":"Zeng","year":"2019","journal-title":"J Bone Min Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.7498","article-title":"Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement","volume":"319","author":"Curry","year":"2018","journal-title":"Jama"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2269","article-title":"The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density At the Femoral Neck or Lumbar Spine","volume":"29","author":"Wright","year":"2014","journal-title":"J Bone Min Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S1550-8579(04)80013-5","article-title":"Osteoporosis Screening of Postmenopausal Women in the Primary Care Setting: A Case-Based Approach","volume":"1","author":"Edwards","year":"2004","journal-title":"Gender Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.8.1545","article-title":"Cytokines and Bone Loss in a 5-Year Longitudinal Study\u2013Hormone Replacement Therapy Suppresses Serum Soluble Interleukin-6 Receptor and Increases interleukin-1-receptor Antagonist: The Danish Osteoporosis Prevention Study","volume":"15","author":"Abrahamsen","year":"2000","journal-title":"J Bone Min Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr2970w","article-title":"Gender Disparities in Osteoporosis","volume":"9","author":"Alswat","year":"2017","journal-title":"J Clin Med Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis Prevention, Diagnosis, and Therapy","volume":"285","year":"2001","journal-title":"Jama"},{"key":"B24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.maturitas.2015.09.009","article-title":"Osteoporosis Screening in Postmenopausal Women Aged 50-64 Years: BMI Alone Compared With Current Screening Tools","volume":"83","author":"Jiang","year":"2016","journal-title":"Maturitas"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2010.51.6.857","article-title":"Relation Between Obesity and Bone Mineral Density and Vertebral Fractures in Korean Postmenopausal Women","volume":"51","author":"Kim","year":"2010","journal-title":"Yonsei Med J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3390\/ijerph13111067","article-title":"Diabetes and Obesity as Independent Risk Factors for Osteoporosis: Updated Results From the ROIS\/EMEROS Registry in a Population of Five Thousand Post-Menopausal Women Living in a Region Characterized by Heavy Environmental Pressure","volume":"13","author":"Neglia","year":"2016","journal-title":"Int J Environ Res Public Health"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2569","article-title":"Longer Duration of Diabetes Strongly Impacts Fracture Risk Assessment: The Manitoba BMD Cohort","volume":"101","author":"Majumdar","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-1677","article-title":"Increased Bone Adiposity and Peroxisomal Proliferator-Activated Receptor-Gamma2 Expression in Type I Diabetic Mice","volume":"146","author":"Botolin","year":"2005","journal-title":"Endocrinology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2016.2457","article-title":"Bradykinin Receptors and EphB2\/EphrinB2 Pathway in Response to High Glucose-Induced Osteoblast Dysfunction and Hyperglycemia-Induced Bone Deterioration in Mice","volume":"37","author":"Wu","year":"2016","journal-title":"Int J Mol Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"696","DOI":"10.7150\/ijms.32707","article-title":"Hyperglycemia Inhibits Osteoblastogenesis of Rat Bone Marrow Stromal Cells Via Activation of the Notch2 Signaling Pathway","volume":"16","author":"Huang","year":"2019","journal-title":"Int J Med Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-00160","article-title":"Advanced Glycation End Products (Ages), Receptor for AGEs, Diabetes, and Bone: Review of the Literature","volume":"3","author":"Asadipooya","year":"2019","journal-title":"J Endocrine Soc"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201802805RR","article-title":"Activation of ROS\/Mapks\/NF-\u03bab\/NLRP3 and Inhibition of Efferocytosis in Osteoclast-Mediated Diabetic Osteoporosis","volume":"33","author":"An","year":"2019","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1023\/A:1006816223292","article-title":"Effects of Advanced Glycation End-Products on the Proliferation and Differentiation of Osteoblast-Like Cells","volume":"170","author":"McCarthy","year":"1997","journal-title":"Mol Cell Biochem"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1080\/13813450701602523","article-title":"Advanced Glycation Endproducts Influence the mRNA Expression of RAGE, RANKL and Various Osteoblastic Genes in Human Osteoblasts","volume":"113","author":"Franke","year":"2007","journal-title":"Arch Physiol Biochem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.02.091","article-title":"Effects of High Glucose and Advanced Glycation End Products on the Expressions of Sclerostin and RANKL as Well as Apoptosis in Osteocyte-Like MLO-Y4-A2 Cells","volume":"461","author":"Tanaka","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-012-9641-2","article-title":"Advanced Glycation End Products (Ages), But Not High Glucose, Inhibit the Osteoblastic Differentiation of Mouse Stromal ST2 Cells Through the Suppression of Osterix Expression, and Inhibit Cell Growth and Increasing Cell Apoptosis","volume":"91","author":"Okazaki","year":"2012","journal-title":"Calcified Tissue Int"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1818","article-title":"Advanced Glycation End Product 3 (AGE3) Suppresses the Mineralization of Mouse Stromal ST2 Cells and Human Mesenchymal Stem Cells by Increasing TGF-beta Expression and Secretion","volume":"155","author":"Notsu","year":"2014","journal-title":"Endocrinology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-2631-7","article-title":"High Serum Pentosidine But Not esRAGE is Associated With Prevalent Fractures in Type 1 Diabetes Independent of Bone Mineral Density and Glycaemic Control","volume":"25","author":"Neumann","year":"2014","journal-title":"Osteoporosis Int"},{"key":"B39","article-title":"Correlation Analysis of Urine Proteins and Inflammatory Cytokines With Osteoporosis in Patients With Diabetic Nephropathy","volume":"18","author":"Zhao","year":"2018","journal-title":"J Musculoskeletal Neuronal Interact"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-0669-7_10","article-title":"In Vitro Investigation of the Roles of the Proinflammatory Cytokines Tumor Necrosis Factor-Alpha and Interleukin-1 in Murine Osteoclastogenesis","volume":"1155","author":"Jules","year":"2014","journal-title":"Methods Mol Biol (Clifton NJ)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3200","article-title":"Increasing Adiposity is Associated With Higher Adipokine Levels and Lower Bone Mineral Density in Obese Older Adults","volume":"99","author":"Aguirre","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.251534698","article-title":"Up-Regulation of TNF-Producing T Cells in the Bone Marrow: A Key Mechanism by Which Estrogen Deficiency Induces Bone Loss In Vivo","volume":"98","author":"Roggia","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2008.08.012","article-title":"The Incretin System and its Role in Type 2 Diabetes Mellitus","volume":"297","author":"Holst","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01949","article-title":"Glucose-Dependent Insulinotropic Polypeptide (Gip) Inhibits Bone Resorption Independently of Insulin and Glycemia","volume":"103","author":"Christensen","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00364.2006","article-title":"Effects of Glucose-Dependent Insulinotropic Peptide on Osteoclast Function","volume":"292","author":"Zhong","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2014.29.4.567","article-title":"Expression of Glucagon-Like Peptide 1 Receptor During Osteogenic Differentiation of Adipose-Derived Stem Cells","volume":"29","author":"Jeon","year":"2014","journal-title":"Endocrinol Metab (Seoul Korea)"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2016.00074","article-title":"Mr-Based Assessment of Bone Marrow Fat in Osteoporosis, Diabetes, and Obesity","volume":"7","author":"Cordes","year":"2016","journal-title":"Front Endocrinol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.bone.2017.02.001","article-title":"Vertebral Bone Marrow Fat, Bone Mineral Density and Diabetes: The Osteoporotic Fractures in Men (MrOS) Study","volume":"97","author":"Sheu","year":"2017","journal-title":"Bone"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12718","article-title":"Clinical Implications of Bone Marrow Adiposity","volume":"283","author":"Veldhuis-Vlug","year":"2018","journal-title":"J Internal Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-013-0076-y","article-title":"How to Decide Intervention Thresholds Based on FRAX in Central South Chinese Postmenopausal Women","volume":"45","author":"Zhang","year":"2014","journal-title":"Endocrine"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.531904\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:31:26Z","timestamp":1620977486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.531904\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,14]]},"references-count":50,"alternative-id":["10.3389\/fendo.2021.531904"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.531904","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,14]]},"article-number":"531904"}}